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A B S T R A C T 
Introduction: There are no recent data on nipple 
discharge and its association with malignancy in 
Hong Kong Chinese women. This study reported 
our 5-year experience in the management of 
patients with nipple discharge, and our experience of 
mammography, ultrasonography, ductography, and 
nipple discharge cytology in an attempt to determine 
their role in the management of nipple discharge.
Methods: Women who attended our Breast Clinic 
in a university-affiliated hospital in Hong Kong were 
identified by retrospective review of clinical data from 
January 2007 to December 2011. They were divided 
into benign and malignant subgroups. Background 
clinical variables and investigative results were 
compared between the two subgroups. We also 
reported the sensitivity, specificity, and positive 
and negative predictive values of the investigations 
that included mammography, ultrasonography, 
ductography, and cytology. 
Results: We identified 71 and 31 patients in the 
benign and malignant subgroups, respectively. 
The median age at presentation for the benign 
subgroup was younger than that of the malignant 
subgroup (48 vs 59 years; P=0.003). A higher 
proportion of patients in the malignant subgroup 
than the benign subgroup presented with blood-
stained nipple discharge (87.1% vs 47.9%; P=0.002). 
Mammography had a specificity of 98.4% and 
Implications of nipple discharge in Hong Kong 
Chinese women
Introduction
Nipple discharge is a relatively uncommon complaint 
in Hong Kong Chinese women. According to a 
study in 1997, nipple discharge constituted 1.5% of 
all presenting complaints for women who attended 
a breast clinic in Hong Kong.1  On the contrary, 
nipple discharge accounted for up to 4% to 7% of all 
presenting symptoms in other studies.2,3 This may 
be better explained by the unique Chinese culture 
and help-seeking pattern rather than a true disease 
pattern. With this understanding, any clinical survey 
New knowledge added by this study
• Blood-stained nipple discharge and an associated breast mass at presentation could suggest a higher chance of 
malignancy.
Implications for clinical practice or policy
• A period of watchful waiting is a reasonable alternative to surgical intervention in patients with inferred benign 
pathology.
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will probably underestimate the prevalence of 
nipple discharge in Chinese women. When patients 
approach health care professionals because of nipple 
discharge, not only is it important to differentiate 
malignant from benign causes of nipple discharge, 
it is also a valuable opportunity to promote breast 
health awareness.  
 Numerous studies have demonstrated the 
relationship between breast cancer and nipple 
discharge, with malignancy reported in up to 9.3% 
to 21% of all patients who present with nipple 
ORIGINAL ARTICLECME
positive predictive value of 66.7%; ultrasonography 
had a specificity of 87.0% and negative predictive 
value of 75.0%. Cytology and ductography were 
sensitive but lacked specificity. Ductography had a 
negative predictive value of 100% but a low positive 
predictive value (14.0%). Clinical variables including 
age at presentation, duration of discharge, colour of 
discharge, presence of an associated breast mass, 
and abnormal sonographic findings were important 
in suggesting the underlying pathology of nipple 
discharge. Multiple logistic regression showed that 
blood-stained discharge and an associated breast 
mass were statistically significantly more common 
in the malignant subgroup.
Conclusions: In patients with non–blood-
stained nipple discharge, a negative clinical breast 
examination combined with negative imaging could 
reasonably infer a benign underlying pathology.
This article was 
published on 5 Jan 
2018 at www.hkmj.org.
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香港華籍女性乳頭溢液的預示
簡偉文、陳梓欣、鄺靄慧
引言：近代文獻中未有關於香港華籍女性乳頭溢液以及其相關惡性腫
瘤的資料。本研究報告我們5年來處理有關乳頭溢液病例的經驗，並
回顧乳房X光造影、超聲檢查、乳管造影和乳頭溢液細胞學檢查的病
例，從而確定這些檢測在乳頭溢液治療過程中的角色。
方法：回顧分析2007年1月至2011年12月期間，所有到香港一所大學
教學醫院的乳房護理診所求診的病人的臨床資料。我們把病人分為良
性和惡性腫瘤兩組，然後比較兩組的背景臨床資料和檢查結果，並報
告乳房X光造影、超聲檢查、細胞學和乳管造影檢查的敏感性、特異
性，以及其陽性和陰性預測值。
結果：良性和惡性腫瘤兩組分別有71例和31例。良性腫瘤組別的病
人年齡中位數顯著低於惡性腫瘤組別（48歲比59歲；P=0.003）。
惡性腫瘤組別中有較多患者的乳頭有血性溢液（87.1%比47.9%；
P=0.002）。乳房X光造影的特異性98.4%，陽性預測值66.7%；超聲
檢查的特異性87.0%，陰性預測值75.0%。細胞學和乳管造影檢查的敏
感度高，可惜缺乏特異性。乳管造影檢查的陰性預測值有100%，但其
陽性預測值偏低（14.0%）。患者年齡、溢液持續期、溢液顏色、是
否有相關的乳房腫塊和異常的超聲檢查結果，對於反映乳頭溢液的潛
在病理狀況相當重要。多元邏輯迴歸分析顯示惡性腫瘤組別中，患者
的乳頭有血性溢液和相關乳腺腫塊的情況明顯較多。
結論：對於無出現乳頭血性溢液的患者，如果其臨床乳腺檢查和造影
顯像均為陰性時，便可合理地推斷患者屬良性腫瘤的病例。
discharge.4,5 The most challenging role of breast 
surgeons is to accurately identify these patients. 
Notwithstanding, controversy persists about the 
value and accuracy of individual investigative tools 
for nipple discharge.6 
 There are no recent data on nipple discharge 
and its association with malignancy in Chinese 
women in Hong Kong. The primary aim of this 
study was to report our recent experience in the 
management of patients with nipple discharge in 
a single surgical centre. The secondary aim was to 
report our experience of individual investigative 
tools in an attempt to determine their role in the 
management of nipple discharge.
Methods
We retrospectively reviewed the clinical data of 
patients who attended our Breast Clinic at the 
Queen Mary Hospital, a university-affiliated hospital 
in Hong Kong, for nipple discharge from January 
2007 to December 2011. Potential subjects were 
identified when diagnosis coding 611.79 (other 
signs and symptoms in breast) was entered into our 
Clinical Management System, which is a territory-
wide computer-based medical record system 
designed for use in public hospitals, and also from 
the prospective database of the Division of Breast 
Surgery, The University of Hong Kong. 
 Data extraction and coding were performed by 
the first author (WM Kan) and included duration of 
follow-up until December 2011, age at presentation, 
history of breast condition, and laterality and duration 
of nipple discharge before first consultation. Clinical 
variables included colour of nipple discharge, single- 
or multiple-duct discharge, associated symptoms, 
mammographic and ultrasonographic imaging 
results, as well as ductogram and cytology results. 
Pathology results were recorded for patients who 
underwent surgery or biopsy. 
 In order to make a meaningful comparison, 
we divided patients into malignant and benign 
subgroups. The malignant subgroup was defined 
by malignant pathology on a surgically resected 
specimen. The benign subgroup was defined by 
benign pathology of a surgically resected or biopsy 
specimen, or clinical non-progression after more 
than 2 years of follow-up. Patients who did not 
undergo surgery or biopsy and who were followed 
up for less than 2 years were excluded (Fig). 
 In the first part of our study, we compared 
the background clinical variables and investigative 
results between the two subgroups. In the second 
part of our analysis, we reported the sensitivity, 
specificity, positive predictive value, and negative 
predictive value of individual investigative tools. 
 For the purpose of this analysis, we also classified 
the results of clinical examination, mammography, 
ultrasonography, and cytology as ‘test positive’ or 
‘test negative’ for underlying malignancy. Presence 
of a palpable breast mass (regardless of mobility) was 
considered a positive result and no palpable breast 
mass a negative result. For mammographic findings, 
microcalcifications were considered a positive result. 
For ultrasonography, a detectable mass was ‘test 
positive’ for underlying malignancy; non-solitary 
dilated ducts, cysts, and normal ultrasonogram were 
regarded as ‘test negative’. For ductogram results, 
dilated ducts, irregularity, and the presence of ductal 
filling defects were considered positive. For cytology, 
atypical, suspicious, and malignant were considered 
‘test positive’, and benign as ‘test negative’. This study 
was done in accordance with the principles outlined 
in the Declaration of Helsinki. 
Statistical analysis
R version 3.0.2 (the R Foundation) and the SPSS 
(Windows version 14.0; SPSS Inc, Chicago [IL], 
United States) were used for data analysis. To 
determine the differences between subgroups, 
Wilcoxon rank sum test and Fisher’s exact test 
were used for numerical data and categorical 
data, respectively. Multiple logistic regression was 
performed to examine the odds ratios of the factors. 
Backward selection through likelihood ratio test 
with removal of P value of 0.1 was conducted for 
model selection. Variables in univariate analysis with 
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a P value of <0.1 were included in the full model. A P 
value of <0.05 was considered statistically significant. 
Results
Table 1 summarises the first part of our analysis. We 
identified 102 patients who presented to our Breast 
Clinic during the study period. They had either a 
tissue diagnosis or had been followed up for longer 
than 2 years without tissue diagnosis. There were 
31 and 71 patients in the malignant and benign 
subgroups, respectively. 
 The median age at presentation of the benign 
subgroup was significantly younger than that of the 
malignant subgroup (48 vs 59 years; P=0.003). The 
median interval between onset of nipple discharge 
and first presentation was significantly longer in the 
benign subgroup than in the malignant subgroup (13 
vs 4 weeks; P=0.002). 
 Comparing the two subgroups, a larger 
proportion of patients in the malignant subgroup 
presented with blood-stained discharge (87.1% vs 
47.9%; P=0.002) and had a breast mass at presentation 
(46.7% vs 7.0%; P<0.001). For the individual 
investigative modalities, with the exception 
of ultrasonography, neither mammography, 
ductography nor cytology showed any statistically 
significant difference between the malignant and 
benign subgroups. 
 Table 2 summarises the second part of the study. 
We calculated the sensitivity, specificity, and positive 
and negative predictive values of mammographic, 
ultrasonographic, cytological, and ductographic 
findings. There were 83, 95, 27, and 46 patients 
who underwent mammography, ultrasonography, 
cytology, and ductography, respectively. The positive 
and negative predictive values of cytology were 
41.2% and 80.0%, respectively. Ductography had 
a sensitivity of 100%, specificity of 7.5%, positive 
predictive value of 14.0%, and negative predictive 
value of 100%.
 Multiple logistic regression analysis with 
backward selection was performed. Covariates with 
a P value of <0.1 were included in the full model 
(Table 1). By likelihood ratio test and removal of 
variables with a P value of >0.1, duration of nipple 
discharge, colour of nipple discharge, mastalgia, and 
associated mass remained in the final model (Table 
3). 
 Compared with serous, milky and brownish 
discharge, patients with blood-stained discharge 
had a significantly higher risk for malignancy 
(odds ratio=13.368; 95% confidence interval, 
1.926-92.809). In addition, compared with patients 
having no symptoms, those with a breast mass had 
a significantly higher risk for malignancy (odds 
ratio=14.648; 95% confidence interval, 3.155-68.000) 
[Table 3].  
Discussion
A methodologically ideal study of nipple discharge 
would require every patient to undergo the same 
investigations and also surgery for final pathology. 
This, however, would be unethical. For patients 
who opted for non-operative management of nipple 
discharge, our retrospective study considered 2-year 
clinical non-progression a reasonable surrogate for 
benign breast pathology.
Clinical variables
Women in the malignant subgroup were significantly 
FIG.  Algorithm for patient selection
Patients with nipple 
discharge (n=102)
Pathology available 
(n=77)
Malignant subgroup 
(n=31)
Benign subgroup 
(n=71)
Clinical non-progression  
≥2 years (n=25)
Follow-up <2 years 
(n=10)
Excluded
Pathology not available 
(n=35)
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* Data were missing for some patients
TABLE 1.  Bivariate analysis of tumour type (benign or malignant) and other clinical variables
Variable* Median (range) or No. (%) of patients P value (Fisher’s exact/
Wilcoxon rank sum test)
Malignant (n=31) Benign (n=71)
Duration of follow-up (weeks) 129 (9-261) 173 (7-266) 0.190
Age at presentation (years) 59 (36-91) 48 (24-87) 0.003
History of malignancy in contralateral breast 1 (3.2) 3 (4.2) 1
Laterality of nipple discharge (unilateral / bilateral) 29 (93.5) / 2 (6.5) 56 (78.9) / 15 (21.1) 0.085
Duration of nipple discharge before consultation (weeks) 4 (1-26) 13 (1-520) 0.002
Colour of nipple discharge
Serous 3 (9.7) 22 (31.0) 0.002
Milky 1 (3.2) 8 (11.3)
Brownish 0 7 (9.9)
Blood-stained 27 (87.1) 34 (47.9)
Single / multiple duct (n=82)
Single duct 10 (71.4) 59 (86.8) 0.222
Multiple duct 4 (28.6)  9 (13.2)
Associated symptoms (n=101)
No symptoms 14 (46.7) 58 (81.7) <0.001
Mastalgia 2 (6.7) 8 (11.3)
Breast mass 14 (46.7) 5 (7.0)
Mammogram (n=83)
Microcalcifications 2 (9.5) 1 (1.6) 0.156
Normal 19 (90.5) 61 (98.4)
Ultrasonogram (n=95)
Normal 4 (15.4) 34 (49.3) <0.001
Cyst 11 (42.3) 5 (7.2)
Dilated ducts 5 (19.2) 21 (30.4)
Mass 6 (23.1) 9 (13.0)
Ductogram (n=46)
Normal 0 3 (7.5) 0.900
Dilated ducts 2 (33.3) 9 (22.5)
Irregularity 1 (16.7) 7 (17.5)
Filing defect 3 (50.0) 21 (52.5)
Cytology (n=27)
Benign 2 (22.2) 8 (44.4) 0.383
Atypical 5 (55.6) 8 (44.4)
Suspicious 2 (22.2) 1 (5.6)
Malignant 0 1 (5.6)
TABLE 2.  Sensitivity, specificity, and positive/negative predictive values of different modalities
Mammography 
(microcalcifications with 
or without a mass) [n=83]
Ultrasonography (mass) 
[n=95]
Cytology (atypical, 
suspicious, and 
malignant) [n=27]
Ductography (dilated 
ducts, irregularity, and 
filling defect) [n=46] 
Sensitivity 9.5% 23.1% 77.8% 100%
Specificity 98.4% 87.0% 44.4% 7.5%
Positive predictive value 66.7% 40.0% 41.2% 14.0%
Negative predictive value 76.3% 75.0% 80.0% 100%
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older at presentation than their benign counterparts. 
This was in agreement with the fact that physiological 
nipple discharge is more common in younger pre-
menopausal women. Caution should be exercised 
in postmenopausal women who present with 
nipple discharge and the possibility of malignancy 
investigated before concluding a benign pathology. 
 With respect to the colour of nipple discharge, 
underlying benign and malignant causes had a 
different pattern. Benign pathology was more likely 
to be associated with non–blood-stained discharge 
(n=37, 52.1%), whereas malignant pathology was 
more likely to be associated with blood-stained 
discharge (n=27, 87.1%). This is not pathognomonic 
but did reach statistical significance.
 The differentiation between multiple-duct and 
single-duct discharge showed no association with 
underlying pathology. 
Mammography and ultrasonography
As shown in Table 2, mammography had a higher 
specificity of 98.4% and positive predictive value 
of 66.7% but a disappointingly low sensitivity of 
9.5%. Therefore, a normal mammogram did not 
confidently exclude malignancy. On the other hand, 
breast ultrasonography had a specificity and negative 
predictive value of 87.0% and 75.0%, respectively. 
Mammography was routinely offered to patients who 
presented with nipple discharge. Complementary 
breast ultrasonography was also arranged, especially 
for younger Asian women with denser breasts on 
mammography.7 In our experience, complementary 
ultrasonography increases the overall sensitivity 
and negative predictive value compared with 
mammography alone. 
Nipple discharge cytology
Opinion is divided on the value of cytological 
examination. While some studies report a 
complementary diagnostic value and recommend its 
routine use,8,9 others report it has little such value 
and advise against its routine use.10
 Of the 102 patients, 36 had demonstrable 
nipple discharge at consultation with a sample 
collected for examination. Of these 36 specimens, 
only 27 showed a sufficient number of cells to 
make a cytological diagnosis. Nonetheless, we 
attempted to analyse its accuracy. The sensitivity 
and specificity of cytological examination were 
77.8% and 44.4%, respectively. Its positive predictive 
value was disappointingly low at 41.2% and its 
negative predictive value was 80.0%. The diagnostic 
value of this investigation was limited as not every 
patient had demonstrable nipple discharge and not 
every specimen contained adequate cells for testing. 
Nonetheless, this investigation is minimally invasive 
so was always performed if there was demonstrable 
nipple discharge, although it rarely affected the 
clinical decision or plan of management. 
Ductography
The value of ductography is debatable. While 
some studies have validated the diagnostic value of 
preoperative ductography in differentiating benign 
and malignant pathology,11,12 others doubt its value.13 
Rather than differentiating benign and malignant 
pathology, we used preoperative ductogram to aid 
in the localisation of non-palpable lesions.14,15 The 
sensitivity was 100% whereas the specificity was low 
at 7.5%, with a positive predictive value of 14.0% and 
a negative predictive value of 100%. 
Magnetic resonance imaging
Magnetic resonance imaging was not included 
in our routine evaluation of patients with nipple 
discharge although we acknowledge its value in the 
detection of carcinoma in these patients. It has an 
exceptionally high sensitivity for both invasive and 
in-situ carcinoma.16 Its routine use in patients with 
a breast lesion is nonetheless limited by its relatively 
low specificity of 72% (95% confidence interval, 67%-
77%).17 The role of magnetic resonance imaging in 
patients with nipple discharge has been extensively 
validated,18-21 suggesting that it may detect or exclude 
the presence of carcinoma with a high degree of 
certainty. Magnetic resonance imaging may be 
considered when all other available strategies are 
inconclusive. 
TABLE 3.  Multiple logistic regression of factors associated with malignancy
Odds ratio 95% Confidence interval P value
Duration of nipple discharge before consultation 0.969 0.920-1.020 0.227
Colour of nipple discharge (ref: serous / milky / brownish)
Blood-stained 13.368 1.926-92.809 0.009
Associated symptoms (ref: no symptoms)
Mastalgia 8.004 0.698-91.741 0.095
Breast mass 14.648 3.155-68.000 <0.001
#  Implications of nipple discharge in women  # 
23Hong Kong Med J  ⎥  Volume 24 Number 1  ⎥  February 2018  ⎥  www.hkmj.org
Microdochectomy
Emerging evidence suggests that neither clinical 
variables nor preoperative investigations reliably 
distinguish benign and malignant pathology so duct 
excision should be offered to every patient with 
nipple discharge.22-26 We offered microdochectomy 
to patients with no palpable breast lesion based on 
two indications: clinical or radiological suspicion, or 
a patient’s wish to stop nipple discharge by surgery. 
It is likely that offering microdochectomy to all 
patients with nipple discharge would result in over-
treatment, as the final pathology was benign in most 
cases. In patients with negative clinical examination 
and negative imaging findings, a period of watchful 
waiting with regular follow-up is a reasonable 
alternative to surgical intervention. 
 The association of blood-stained discharge 
with malignancy is controversial. Morrogh et 
al24 reported that haemorrhagic discharge did 
not indicate malignancy or high risk, and non-
haemorrhagic discharge did not exclude malignancy. 
In our study, we showed that blood-stained 
discharge was associated with malignancy but was 
not pathognomonic.
 On the other hand, presence of an associated 
breast mass was a significant finding. This may be 
because it is the most common presenting symptom 
of breast cancer, and its incidence rises with age.
Limitations
Our study had several limitations. First, as data 
collection was retrospective, there might have been 
inconsistent or incomplete recording of clinical 
findings. Study subjects might not be representative 
and some data for importable variables might have 
been missing. No blinding during information 
extraction or coding could be achieved as it was 
performed by the first author. Second, the small 
sample size limited the power of our study although 
this could in part be due to the relatively conservative 
culture and help-seeking pattern of Hong Kong 
Chinese women. The unequal arm size also limited 
the interpretation of statistical significance of 
comparisons. Third, our assumption of 2-year clinical 
non-progression as benign pathology might have 
underestimated the true incidence of malignancy 
in our group of patients. Lastly, the small number 
of adequate cytology specimens limited meaningful 
analysis of this investigation. As the sample taken for 
cytology is usually small, it will affect the sensitivity. 
Conclusions
Clinical variables including age at presentation, 
duration and colour of discharge, presence of an 
associated breast mass, and abnormal sonographic 
findings were important in suggesting the underlying 
pathology of nipple discharge. Only blood-stained 
nipple discharge and an associated breast mass 
remained in the multiple logistic regression model 
and were statistically significant. In patients with non–
blood-stained nipple discharge, as well as a negative 
clinical breast examination and imaging, we may infer 
an underlying benign pathology. Further prospective 
studies with a larger sample size are advocated. 
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